UK Government Caught Lying On Baby Hep B Vax Safety

The British Government has been caught lying in a news report in The Mail on Sunday newspaper yesterday about a proposal to give 8 week old British babies Hepatitis B vaccinations: New vaccination fears over plan to give hepatitis jabs at eight weeks old12th April 2009.
A Department of Health spokesman was quoted claiming:-
The safety of children is always paramount whenever decisions are taken regarding what vaccines are included as part of the child vaccination programme.“
But 8 week old babies are not at risk from Hepatitis B, with the potential exception of babies born to mothers from countries with claimed-to-have high rates of infection. Around 2000 British born infants are already being vaccinated annually in the UK. At risk groups are intravenous “recreational” drug abusers and those who practice unsafe sex - which rules out 8 week old babies.
And Hepatitis B vaccine has been shown in many peer reviewed research papers [including from Harvard University - detailed references at end] to be associated with numerous infant deaths in the USA and Europe, multiple sclerosis and numerous chronic auto-immune disorders. These latter include Guillain-Barre syndrome, lupus, rheumatism, blood disorders and chronic fatigue.
There has been a criminal judicial investigation in France into the adverse effects of this vaccine. France was the first country to introduce universal Hepatitis B vaccination and saw effects which included the first ever seen and harrowing cases of childhood multiple sclerosis in France.
Research also shows that the prevalence of Hepatitis B is low in the UK, consistent with previous estimates and suggesting that many infections were acquired outside the UK. This all suggests Government should concentrate its efforts on effective treatment rather than vaccination of infants against a disease which does not affect them. Proponents of the vaccination claim rates of Hepatitis B infection are “spiralling” but based on “estimates”. Regrettably “estimates” can be “pulled” in one direction or another depending on which direction those responsible for the “estimates” are more interested in seeing them move. And in these circumstances, they can never be justification for vaccinating all babies to protect adult drug abusers and practitioners of unsafe sex.
Additionally, UK and EU authorities have withdrawn marketing licences for 6 Hepatitis vaccines claiming a lack of efficacy and and denying in one case [Hexavac] any association with 6 infant deaths in Germany. The deaths were reported in a 2005 research paper as possibly caused by the vaccine: “Unexplained cases of sudden infant death shortly after hexavalent vaccination.” Zinka B, Rauch E, Buettner A, Rueff F, Penning R. - Vaccine. 2005 May 18.
The most recent vaccine to lose its authorisation was last week when the Medicines Healthcare regulatory Agency withdrew GlaxoSmithKline’s Hepatitis B Energix B vaccine marketing authorisation with Professor Kent Woods, chief executive of the MHRA stating:-
The safety of the vaccine is not in question, but it is suspected to be ineffective.” MHRA recalls GSK’s Hepatitis B vaccine - 07 Apr 2009 - Regulatory Affairs - Hays Pharma News
The other most recent vaccine to lose its European marketing authorisation was Quintanrix [also from GSK] in August last year. The other vaccines are: Infanrix [GSK], Hepacare [Celltech] and Primavax [Aventis Pasteur].
So if ‘The safety of children is always paramount’ why the British Department of Health is even contemplating such a vaccine for 8 week old babies is beyond comprehension.”
But there is worse to come and it shows the UK’s New Labour Government has been irresponsible handing recently from 1st April 2009 legal power to dictate vaccination policy exclusively to the Joint Committee on Vaccination and Immunisation: UK Government Hands Drug Industry Control of Childhood Vaccination. The JCVI regrettably has a demonstrable track-record of recklessness on safety up to and including the present day, as shown in FOI documents: British Government’s Reckless Disregard for Child Health Safety and UK Government Hands Drug Industry Control of Childhood Vaccination.
The DoH statement published in The Mail on Sunday is also untrue because:-
Under the new law The Health Protection (Vaccination) Regulations 2009 which came into effect on 1st April for England only, the Secretary of State has no power on the grounds of safety to refuse to implement or reverse any Joint Committe on Vaccination and Immunisation recommendation
the JCVI expressly has no remit to take safety into account in its decision-making
[that role is supposedly the MHRA's but regrettably they seem to rubber stamp a great deal of what the drug industry come up with - as has been shown time and again and not just with vaccines, but drugs like Seroxat - the "anti-depressant" shown not to work compared to placebo and which causes adolescents to be 3 times more likely to commit suicide]
the only consideration the Secretary of State can take into account in rejecting JCVI recommendations is cost-effectiveness - not safety
contrary to the UK Department of Health claims, no childhood vaccines used on British children have ever been tested according to the gold standard of evidence - randomised placebo controlled clinical trials.
health officials refuse to ensure large scale studies of total health outcomes between vaccinated and unvaccinated individuals are carried out. These should show differences in overall health between these groups and some medical professionals believe this is because the studies would reveal the unvaccinated are healthier overall and high levels of chronic diseases in vaccinated individuals.
there is no clinical benefit to infants from Hepatitis B vaccine but infants are put at risk of the known and unknown adverse effects
this also means doctors and nurses are being expected to behave unethically and possibly criminally - because no caring parent will consent to a vaccine administered to an 8 week old baby on being told there are risks but no benefits
The main reason for the new drive to more and more vaccines - and this is well published in the trade press - is that the drug industry has been changing its business model. The financial markets have known for many years the old model would fail - that of patented “blockbuster” drugs:-
the drug industry have made vaccines the new growth area because they highly lucrative
they are drugs everyone gets - it is the same business model of Bill Gates’ Microsoft - pretty much everyone has to have Windows software - pretty much everyone gets vax’d
and the drug industry has been working hard behind-the-scenes to pursuade everyone - especially legislators - that they are vital when they are not and lobbying for changes in law just like this new law - which was introduced without Parliamentary debate and appears to be unlawful per se: UK Government Hands Drug Industry Control of Childhood Vaccination
Dr Marc Girard, a specialist in the side effects of drugs and commissioned as a medical expert by French courts in the French criminal investigation into the introduction of universal Hepatitis B vaccination in France, suggests that even in high-endemic countries, the risk/benefit ratio of what he describes as “this unusually toxic vaccine” must be carefully re-assessed.
Regarding the health situation in the UK Dr Girard says the conclusion not to vaccinate is obvious. France was the first country to implement universal hepatitis B vaccination in 1994.
Whilst other evidence is embargoed by the French Courts, Dr. Marc Girard has also been able to publish a scientific review of the unembargoed evidence of the vaccine’s hazards (Autoimmun Rev 2005; 4: 96-100). Dr Girard shows that French health authorities suppress studies demonstrating serious risks.
Dr Girard has previously said:
Whilst the risk factors for babies have changed little, there is now impressive evidence that for a preventive measure, hepatitis B vaccine is remarkable for the frequency, variety and severity of complications from its use. The toxicity of this vaccine is so unusual that, even if crucial data are regrettably concealed or covered by Court order, scientific evidence is already far higher than normally needed to justify severe restrictive measures.“
______________________________________
REFERENCES
UK & EU MARKETING AUTHORISATION WITHDRAWALS
MHRA recalls GSK’s Hepatitis B vaccine - 07 Apr 2009 - Regulatory Affairs - Hays Pharma News
Public Statement on Quintanrix (Common name: diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b conjugate vaccine) Withdrawal of the Marketing Authorisation in the European Union - 29/08/08 - EMEA/424484/08
EMEA announces recommendation for suspension of the marketing authorisation for Hexavac - EMEA/297369/2005
EMEA Questions and Answers on the suspension of Hexavac - EMEA/304888/2005
EMEA Withdrawal of the Marketing Authorisation for the Medicinal Product Hepacare (Triple hepatitis B recombinant vaccine)EMEA/32933/02- 20/12/02
Public Statement on Hepacare (Triple hepatitis B recombinant vaccine)17/12/02 - EMEA/32933/02
Withdrawal of the Marketing Authorisation for the Medicinal Product Primavax (Diptheria, Tetanus, and Hepatitis B vaccine) - 04/12/00 - EMEA/H/2681/00
______________________________________
DEATHS, MULTIPLE SCLEROSIS AND OTHER ADVERSE EFFECTS
“Unexplained cases of sudden infant death shortly after hexavalent vaccination.” Zinka B, Rauch E, Buettner A, Rueff F, Penning R. - Vaccine. 2005 May 18
Vaccinations are considered to be the most effective and safe method preventing infectious diseases. Although hexavalent vaccines like Hexavac((R)) and Infanrix Hexa((R)) are assumed to be well tolerated and safe regarding the rate of immunity [Liese JG, Stojanov S, Berut F, Minini P, Harzer E, Jow S, et al. Large scale safety study of a liquid hexavalent vaccine (D-T-acP-IPV-PRP-T-HBs) administered at 2, 4, 6 and 12-14 months of age. Vaccine 2002;20:448-54; Mallet E, Fabre P, Pines E, Salomon H, Staub T, Schodel F, et al. Immunogenicity and safety of a new liquid hexavalent combines vaccine compared with separate administration of reference licensed vaccines in infants. Pediatr Infect Dis J 2000;19:1119-27], it was noticed that several cases of death occurred shortly after the vaccination. We report six cases of sudden infant death that occurred within 48h after hexavalent vaccination. At post-mortal examination, those cases showed unusual findings, especially in the brain and in laboratory tests. Crude calculations of local epidemiology are compatible with an association between hexavalent vaccination and unusual cases of sudden infant death. If confirmed in systematic studies, our findings would have potentially serious clinical implications.
Neonatal Deaths After Hepatitis B Vaccine - The Vaccine Adverse Event Reporting System, 1991-1998 - Arch Pediatr Adolesc Med. 1999;153:1279-1282
Results: Of 1771 neonatal reports, there were 18 deaths in 8 boys and 9 girls (1 patient unclassified). The mean age at vaccination for these 18 cases was 12 days(range, 1-27 days); median time from vaccination to onset of symptoms was 2 days (range, 0-20 days); and median time from symptoms to death was 0 days (range, 0-15 days). The mean birth weight of the neonates (n = 15) was 3034 g (range, 1828-4678 g). The causes of death for the 17 autopsied cases were sudden infant death syndrome for 12, infection for 3, and 1 case each of intracerebral hemorrhage, accidental suffocation, and congenital heart disease. Conclusion: Few neonatal deaths following HepB vaccination have been reported, despite the use of at least 86 million doses of pediatric vaccine given in the United States since 1991. While the limitations of passive surveillance systems do not permit definitive inference, these data suggest that HepB immunization is not causing a clear increase in neonatal deaths.
Recombinant hepatitis B vaccine and the risk of multiple sclerosis
NEUROLOGY 2004;63:838-842
A prospective study
Miguel A. Hernán, MD, DrPH, Susan S. Jick, DSc, Michael J. Olek, DO and Hershel Jick, MD
From the Department of Epidemiology (Dr. Hernán), Harvard School of Public Health, Boston; Boston Collaborative Drug Surveillance Program (Drs. Susan S. Jick and Hershel Jick), Boston University, Lexington, MA; and Department of Neurology (Dr. Olek), College of Medicine, University of California, Irvine.
Background: A potential link between the recombinant hepatitis B vaccine and an increased risk of multiple sclerosis (MS) has been evaluated in several studies, but some of them have substantial methodologic limitations.
Methods: The authors conducted a nested case-control study within the General Practice Research Database (GPRD) in the United Kingdom. The authors identified patients who had a first MS diagnosis recorded in the GPRD between January 1993 and December 2000. Cases were patients with a diagnosis of MS confirmed through examination of medical records, and with at least 3 years of continuous recording in the GPRD before their date of first symptoms (index date). Up to 10 controls per case were randomly selected, matched on age, sex, practice, and date of joining the practice. Information on receipt of immunizations was obtained from the computer records.
Results: The analyses include 163 cases of MS and 1,604 controls. The OR of MS for vaccination within 3 years before the index date compared to no vaccination was 3.1 (95% CI 1.5, 6.3). No increased risk of MS was associated with tetanus and influenza vaccinations.
Conclusions: These findings are consistent with the hypothesis that immunization with the recombinant hepatitis B vaccine is associated with an increased risk of MS, and challenge the idea that the relation between hepatitis B vaccination and risk of MS is well understood.
Received March 31, 2004. Accepted in final form May 8, 2004.
“Multiple sclerosis and hepatitis B vaccination: Adding the credibility of molecular biology to an unusual level of clinical and epidemiological evidence” Comenge Y; Girard M (Med Hypotheses, doi 10.1016/j.mehy.2005.08.012)
“Autoimmune hazards of hepatitis B vaccine” Girard M (Autoimmun Rev 2005; 4:96-100) (Text available in electronic form on request.)
______________________________________
Low Prevalence in The UK of Hepatitis B and Infections acquired abroad
The prevalence of hepatitis B infection in adults in England and Wales - Epidemiology and Infection (1999), 122:133-138 Cambridge University Press
Cost effectiveness analyses of alternative hepatitis B vaccination programmes in England and Wales require a robust estimate of the lifetime risk of carriage. To this end, we report the prevalence of infection in 3781 anonymized individuals aged 15–44 years whose sera were submitted in 1996 to 16 microbiology laboratories in England and Wales. One hundred and forty-six individuals (3·9%) were confirmed as anti HBc positive, including 14 chronic carriers (0·37%). The prevalence of infection and carriage was higher in samples collected in London and increased with age. No increased risk of infection was seen in sera from genito-urinary (GUM) clinics. Only 15 sera positive for hepatitis B were also positive for hepatitis C. Our results confirm the low prevalence of hepatitis B in England and Wales, are consistent with previous estimates of carriage and suggest that many infections were acquired while resident outside the UK. Future prevalence studies should determine the country of birth and other risk factors for each individual in order to confirm these findings. (Accepted September 14 1998)

Hepatitis B Shot/High Bilirubin/ ASD CONNECTION

http://www.labtests%20online.org/%20understanding/%20analytes/%20bilirubin/%20test.html

Also known as: Total bilirubin, TBIL, Neonatal bilirubin, Direct bilirubin (conjugated bilirubin), Indirect bilirubin (unconjugated bilirubin) Formal name: Bilirubin Related tests: Liver panel, Gamma-glutamyl transferase, Alkaline phosphatase, Aspartate aminotransferase, Alanine aminotransferase, Hepatitis A, Hepatitis B, Hepatitis C

The Test

How is it used?When is it ordered?What does the test result mean?Is there anything else I should know?

How is it used?
When bilirubin levels are high, a condition called jaundice occurs, and further testing is needed to determine the cause. Too much bilirubin may mean that too much is being produced (usually due to increased hemolysis) or that the liver is incapable of adequately removing bilirubin in a timely manner due to blockage of bile ducts, liver diseases such as cirrhosis, acute hepatitis, or inherited problems with bilirubin processing.

It is not uncommon to see high bilirubin levels in newborns, typically 1 to 3 days old. This is sometimes called physiologic jaundice of the newborn. Within the first 24 hours of life, up to 50% of full-term newborns, and an even greater percentage of pre-term babies, may have a high bilirubin level. After birth, newborns begin breaking down the excess red blood cells (RBCs) they are born with and, since the newborn’s liver is not fully mature, it is unable to process the extra bilirubin, causing the infant's bilirubin levels to rise in the blood and other body tissues. This situation usually resolves itself within a few days. In other instances, newborns’ red blood cells may be being destroyed because of blood incompatibilities between the baby and her mother, called hemolytic disease of the newborn.

In adults or older children, bilirubin is measured to diagnose and/or monitor liver diseases, such as cirrhosis, hepatitis, or gallstones. Patients with sickle cell disease or other causes of hemolytic anemia may have episodes where excessive RBC destruction takes place, increasing bilirubin levels.

When is it ordered?
A doctor usually orders a bilirubin test in conjunction with other laboratory tests (alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase) for a patient who shows signs of abnormal liver function. A bilirubin level may be ordered when a patient:
shows evidence of jaundice has a history of drinking excessive amounts of alcohol has suspected drug toxicity has been exposed to hepatitis viruses
Other symptoms that may be present include:dark, amber-colored urine nausea/vomiting abdominal pain and/or swelling fatigue and general malaise that often accompany chronic liver disease
Determining a bilirubin level in newborns with jaundice is considered standard medical care.

What does the test result mean?NOTE: A standard reference range is not available for this test. Because reference values are dependent on many factors, including patient age, gender, sample population, and test method, numeric test results have different meanings in different labs. Your lab report should include the specific reference range for your test. Lab Tests Online strongly recommends that you discuss your test results with your doctor. For more information on reference ranges, please read
Reference Ranges and What They Mean.

Newborns: Excessive bilirubin damages developing brain cells in infants (kernicterus) and may cause mental retardation, learning and developmental disabilities, hearing loss, or eye movement problems. It is important that bilirubin in newborns does not get too high. When the level of bilirubin is above a critical threshold, special treatments are initiated to lower it. An excessive bilirubin level may result from the accelerated breakdown of red blood cells due to a blood type incompatibility between the mother and her newborn (e.g., the mother is Rh-negative and has antibody to Rh-positive blood - the father is Rh-positive, and the fetus inherits this trait from him; the mother’s antibody crosses the placenta and causes the fetal Rh-positive red blood cells to hemolyze, resulting in excessively elevated bilirubin levels with jaundice, anemia, and possible kernicterus. )

Adults and children: Bilirubin levels can be used to identify liver damage/disease or to monitor the progression of jaundice. Increased total or unconjugated bilirubin may be a result of hemolytic, sickle cell or pernicious anemias or a transfusion reaction. If conjugated bilirubin is elevated, there may be some kind of blockage of the liver or bile ducts, hepatitis, trauma to the liver, cirrhosis, a drug reaction, or long-term alcohol abuse.

Inherited disorders that cause abnormal bilirubin metabolism (Gilbert’s, Rotor’s, Dubin-Johnson, Crigler-Najjar syndromes) may also cause increased levels
.
Low levels of bilirubin are not generally a concern and are not monitored.

Is there anything else I should know?
Although bilirubin may be toxic to brain development in newborns (up to the age of about 2–4 weeks), high bilirubin in older children and adults does not pose the same threat. In older children and adults, the “blood-brain barrier” is more developed and prevents bilirubin from crossing this barrier to the brain cells. Elevated bilirubin levels in children or adults, however, strongly suggest a medical condition that must be evaluated and treated.
Bilirubin is not normally present in the urine. However, conjugated bilirubin is water-soluble and therefore may be excreted from the body in the urine when levels increase in the body. Its presence in the urine usually indicates blockage of liver or bile ducts, hepatitis or some other liver damage. The most common method for detecting urine bilirubin is using the dipstick test that is part of a urinalysis.

Bilirubin levels tend to be slightly higher in males than females, while African Americans show lower values. Strenuous exercise may also increase bilirubin levels.

Researchers find aggressive phototherapy can improve neurodevelopmental outcomes in some preemies:
http://www.cnsfoundation.org/site/News2?news_iv_ctrl=-1&page=NewsArticle&id=8235&autologin=true

Engerix hep B vaccine may raise risk of MS in kids:
http://www.nlm.nih.gov/medlineplus/news/fullstory_69759.html

Hepatitis B Vaccine & Adverse Reactions: http://www.umm.%20edu/altmed/%20drugs/hepatitis-%20b-061000.%20htm

Multiple sclerosis reported following administration of hepatitis B and other vaccines: http://us.gsk.com/products/assets/us_engerixb.pdf

Disturbing facts:
- Bilirubin levels tend to be slightly higher in males than females (just like ASD)
- Newborns: Excessive bilirubin damages developing brain cells in infants (kernicterus) and may cause mental retardation, learning and developmental disabilities, hearing loss, or eye movement problems. It is important that bilirubin in newborns does not get too high.
- Reasonst to test an infant are:If they have been exposed to hepatitis viruses (vaccine:Hep B at second day of birth in the hospiital)
- shows evidence of jaundice
- last but not least there is a well documented connection between Hep B vaccine and MS in children.

All this symptoms and facts were present after my son received Hep B vaccine prior to leaving the hospital... One thing it does not mention is the nonstop crying (his voice went horse before we even left the hospital...) He was eating and sleeping fine prior to the shot and developed intolerance to protein after that... and just told me he was a coliky baby and dismissed any observation I had... And told me to go home and put my boy in the sun as much as posible... they never tested levels of bilirubin at all... I could tell he was in a very intence pain and kept on giving Tylenol (which depletes glutathione levels) prescribed by the Pediatrician, probably making things worse!!!
I wish I knew then what I know now...And each time he received a new vaccine he kept having rashes and what not... until 1 year of age when he received MMR and a Flu shot all in one day... after that he went off the deep end and regressed more and more!!! Having very low muscle tone, difficulty with fine motor skills, Sleep depravation, difficulty digesting certain proteins, bloating, pain, and fatigue (this are all symptoms of my child having liver and brain damage). That Hep B shot was the first step we took & started our journey in to ASD world...

And if you add to this the Mercury, Aluminum as well as other aditives in the shots, which have been recently discussed in the theory of vaccines causing micro-vascular stokes from Dr. Moulden... It just makes more sense ... Our children have been injured... vaccine by vaccine and all of them contribute to more and more regressions!!! MMR is just the tip of the iceberg & the straw that broke the camel's back...

With love and concern for the safety of our children, Gabby. :0)

Hello, My name is Gabby, and I am a mother of two AUTISTIC boys: Joshua (4.5 years old) & Nicholas (2.5 years old)...

My earliest memories daydreaming about just being a wife and mother ... I met my soulmate and it was only a matter of time before the rest of my dreams were realized. I was sooooo excited and filled with Joy, Hopes, and dreams for my son to be... Joshua was born on October of 2003... a perfect little boy!!! He flipped over from back to front while he was being weighed for the first time, a strong child indeed...he fed well and slept all night long!!! But this was soon to end... before we left the hospital they took him to the nursery to get a shot (Hep B) so that he would be "safe"... When they brought him back all had changed, and this calm and serene child, would not stop crying. He became horse...and unable to cry like a normal child!!! He did not eat well, stopped sleeping through the night, and day. He was also jaundice...They would tell me over and over that he was OK, that he was a "colicky child"... What ever that means!

As he received more vaccines his condition deteriorated more and more, That strong child became weak, low muscle tone, eye contact started to fade away, and language stopped. It all became more intense after his flu shot at 12months. But the pediatrician kept reassuring me that I was being paranoid, that the vaccines had nothing to do with all his problems...
January 9th 2006, Joshua was diagnosed as SEVERELY AUTISTIC. A week prior to this I was diagnosed with CANCER ( lymphoma type B). Our second child Nicholas was only 5 months old!!! Breastfeeding had to be stopped. In preparation for upcoming Chemo – I had to have a procedure that would insert a Life Port in my chest, to be able to receive the chemo. Later came the radiation... Thank God for family – our support system!


Once Nicholas became 18 months, he received the same diagnosis "AUTISM"... our world was shattered and all our hopes and dreams for our children were tossed away as we were told that there was nothing that could be done, but wait and expect the worse the older they got!!! But, giving up on our boys was not an option for us, I fought and survived CANCER so that we could beat AUTISM too!!!

Unable to work because of my busy schedule as a "spectrum mom" and with limited funds, I started to research in every way possible. Our boys have received alternative treatments, some improvement here and there, but they have been neurologically tested and need STEM CELL & Hyperbaric Oxygen Therapy to repair the brain-injury caused by toxins and fevers associated with them.... All this is not covered by insurance so we don't have the means to pay for all of this much needed treatments!!! Their language has been impaired and have no voice to let me know when they are hungry, sad or in pain... Time is ticking for them... Please help us to help them...


We cannot do this alone... they need you!!!


Love, Gabby. :0)